Top Markets
Coin of the day
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Classement en actions #24961
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Prix de l'action
$1.16
Capitalisation boursière
$54.87M
Changement (1 jour)
-0.38%
Changement (1 an)
-73.81%
Pays
SE
Échange Xspray Pharma AB (publ) (XSPRAY)

Catégorie

Le prix XSPRAY avec la capitalisation boursière de B
Xspray Pharma AB (publ) Xspray Pharma AB (publ)
XSPRAY
$1.16
Capitalisation boursière de Xspray Pharma AB (publ)(XSPRAY)
Capitalisation boursière: $54.87M
En August 2026, Xspray Pharma AB (publ) a une capitalisation boursière de $54.87M. Cela fait de Xspray Pharma AB (publ) la 24961st entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Xspray Pharma AB (publ) du 2017 au 2026
XSPRAY par rapport au top 5 des plus populaires stocks
Prix pour XSPRAY L’actif B La capitalisation boursière de B Résultats
Xspray Pharma AB (publ) Xspray Pharma AB (publ)
$110,864 $54.87M
$5.257T +9,580,746.93%
Xspray Pharma AB (publ) Xspray Pharma AB (publ)
$96,983.21 $54.87M
$4.599T +8,381,149.04%
Xspray Pharma AB (publ) Xspray Pharma AB (publ)
$86,605.73 $54.87M
$4.107T +7,484,331.52%
Xspray Pharma AB (publ) Xspray Pharma AB (publ)
$75,442.43 $54.87M
$3.577T +6,519,604.30%
Xspray Pharma AB (publ) Xspray Pharma AB (publ)
$59,204.63 $54.87M
$2.807T +5,116,339.55%